Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine for Reversal of Neuromuscular Blockade in Children
NCT05053594Phase 4Unknown
- Sponsor
- Pontifícia Universidade Católica de São Paulo
- Start
- Oct 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of neostigmine in neuromuscular blockade (NMB), sponsored by Pontifícia Universidade Católica de São Paulo. Status: unknown.
02
Drugs
neostigmine
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT05053594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05053594.